Galapagos NV ADR (GLPG NASDAQ) stock market data APIs
$31.8759
-0.18(-0.6%)
as of December 4, 2025
Try our APIs with
free plan!
Galapagos NV ADR Financial Data Overview
Price chart is built with
Anychart
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Prev. Close
31.8759
Open
31.6977
High
32.1439
Low
31.6972
52 wk Range
22.36-37.78
Market Cap
2 124 M
Shares Outstanding
65 897 K
Revenue
287 M
EPS
-3.54
Beta
-0.05
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Galapagos NV ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Galapagos NV ADR data using free add-ons & libraries
Get Galapagos NV ADR Fundamental Data
Galapagos NV ADR Fundamental data includes:
- Net Revenue: 287 M
- EBITDA: -277 266 240
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.3529
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Galapagos NV ADR News
New
Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You?
Key Points San Diego-based Tang Capital Management added 400,000 PTC Therapeutics shares in the third quarter. The value of the position increased by $38.3 million quarter over quarter. Tang Capital ...
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In
Key Points San Diego-based Tang Capital Management bought nearly 1.2 million CELC shares. The move helped increase the fund's reported holdings in CELC by $56.8 million from quarter to quarter. It al...
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?
Key Points San Diego-based Tang Capital Management initiated new stake: up 12,400,000 shares, an estimated $40.8 million Change represents 1.6% of reportable assets under management Post-trade holdin...
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?
Key Points San Diego-based Tang Capital Management increased its position in AUPH by 1.3 million shares in the third quarter. Following the transaction, Tang reported holding more than 11.3 million A...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
